Loading...
•
Dec 31, 2022
Balchem Q4 2022 Earnings Report
Balchem reported a growth in net sales and adjusted EBITDA, but a decrease in GAAP net earnings compared to the prior year quarter.
Key Takeaways
Balchem Corporation reported a 9.1% increase in fourth-quarter net sales, reaching $232.5 million. Adjusted EBITDA rose by 14.6% to $52.3 million, while GAAP net earnings decreased by 14.2% to $21.4 million. The company's adjusted earnings per share increased to $0.94.
Net sales increased by 9.1% to $232.5 million due to growth in Human Nutrition & Health and Specialty Products segments.
Adjusted EBITDA increased by 14.6% to $52.3 million.
GAAP net earnings decreased by 14.2% to $21.4 million, resulting in GAAP earnings per share of $0.66.
Adjusted net earnings increased by 9.1% to $30.3 million, resulting in adjusted earnings per share of $0.94.
Balchem
Balchem
Balchem Revenue by Segment
Revenue by Segment
Human Nutrition & Health Revenue
CapyFin.comAnimal Nutrition & Health Revenue
CapyFin.comSpecialty Products Revenue
CapyFin.com Forward Guidance
Balchem is well-positioned to drive continued growth and progress on its strategic growth initiatives while managing through the new challenges expected within this dynamic global market environment in 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income